Anti-HBc-nonreactive occult hepatitis B infections with HBV genotypes B and C in vaccinated immunocompetent adults.
HBV variants
anti-HBs
blood donors
hepatitis B vaccine
hepatitis B virus
occult infection
viral DNA
Journal
Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
07
03
2022
accepted:
01
07
2022
pubmed:
26
7
2022
medline:
12
10
2022
entrez:
25
7
2022
Statut:
ppublish
Résumé
Absence of anti-HBc reactivity with detectable anti-HBs was observed in blood donors with occult hepatitis B virus (HBV) infection (OBI). The prevalence and mechanisms underlying this uncommon condition were investigated over time in Chinese blood donors with OBI. Isolated anti-HBs OBI status was identified from 466,911 donors from Dalian, China, and monitored in follow-up (range: 2.6-84.3 months). HBV vaccination status was documented, and infecting viral strains were characterized. Of 451 confirmed OBIs (1:1035), 43 (9.5%; 1:10,858) had isolated anti-HBs as only serological marker. Isolated anti-HBs OBIs differed from anti-HBc-reactive OBIs by significantly younger age (median 24 years), higher HBV DNA (median: 20 IU/ml) and anti-HBs (median 60.5 IU/L) levels, paucity of mutations in HBV Core and S proteins, and high vaccination rate (72%). Vaccinated isolated anti-HBs OBIs (n = 31) differed from unvaccinated (n = 11) by significantly younger age (22 vs 38 years), higher anti-HBs level at index (48% vs 9% with anti-HBs >100 IU/L) and higher frequency of anti-HBs immune response (44% vs 20%). Of 15 vaccinated and 5 unvaccinated OBIs follow-up, 65% (8 vaccinated and 5 unvaccinated) became HBV DNA negative suggesting aborted recent infection, while 35% (7 vaccinated) had low persistent viraemia 2 to 65 months post index. In conclusion, isolated anti-HBs OBI in Chinese blood donors appears associated with young, vaccinated, adults exposed to HBV who predominantly develop low level aborted infection revealed by transient HBV DNA and immune anti-HBs response. However, a subset of individuals still experienced low but persistent viral replication whose clinical outcome remains uncertain.
Identifiants
pubmed: 35876456
doi: 10.1111/jvh.13733
pmc: PMC9804389
doi:
Substances chimiques
DNA, Viral
0
Hepatitis B Antibodies
0
Hepatitis B Core Antigens
0
Hepatitis B Surface Antigens
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
958-967Informations de copyright
© 2022 The Authors. Journal of Viral Hepatitis published by John Wiley & Sons Ltd.
Références
J Clin Virol. 2017 Aug;93:46-52
pubmed: 28622640
Emerg Microbes Infect. 2019;8(1):1337-1346
pubmed: 31516090
J Viral Hepat. 2017 Aug;24(8):645-653
pubmed: 28182307
Transfusion. 2009 Jun;49(6):1126-35
pubmed: 19392770
J Med Virol. 2017 Dec;89(12):2130-2137
pubmed: 28543299
PLoS One. 2016 Nov 11;11(11):e0166317
pubmed: 27835694
J Infect Dis. 2014 Mar;209(6):845-54
pubmed: 24158960
Clin Vaccine Immunol. 2013 Feb;20(2):269-75
pubmed: 23254298
J Viral Hepat. 2022 Nov;29(11):958-967
pubmed: 35876456
J Med Virol. 1999 Aug;58(4):325-31
pubmed: 10421397
J Hepatol. 1993 Feb;17(2):150-4
pubmed: 8445229
Hepatology. 1992 Jul;16(1):24-30
pubmed: 1535607
N Engl J Med. 2011 Jan 20;364(3):236-47
pubmed: 21247314
Blood Transfus. 2014 Apr;12(2):172-9
pubmed: 24333061
Gut. 2019 Feb;68(2):313-321
pubmed: 29959168
J Hepatol. 2008 Oct;49(4):537-47
pubmed: 18602718
Ann Intern Med. 2005 Mar 1;142(5):333-41
pubmed: 15738452
Front Microbiol. 2020 Dec 14;11:616023
pubmed: 33381105
J Hepatol. 1996 Feb;24(2):155-60
pubmed: 8907568
Medicine (Baltimore). 2016 Dec;95(49):e5625
pubmed: 27930595
Int J Infect Dis. 2020 Mar;92:38-45
pubmed: 31877352
Intervirology. 2001;44(4):243-9
pubmed: 11509887
PLoS One. 2013 Aug 12;8(8):e70768
pubmed: 23951004
Hepatol Int. 2020 Jul;14(4):503-512
pubmed: 32472310
J Hepatol. 2019 Aug;71(2):397-408
pubmed: 31004683
Transfusion. 2017 Jan;57(1):24-35
pubmed: 27673757
Gut. 2012 Dec;61(12):1744-53
pubmed: 22267593
Front Microbiol. 2021 Aug 06;12:695384
pubmed: 34421849
Liver Int. 2020 Jan;40(1):92-100
pubmed: 31518482
Blood Transfus. 2022 Jan;20(1):8-17
pubmed: 33370226
J Viral Hepat. 2017 Sep;24(9):797-803
pubmed: 28342241
Transfusion. 2020 Feb;60(2):334-342
pubmed: 31909495
Liver Int. 2019 Jun;39(6):1052-1061
pubmed: 30790411
J Clin Virol. 2009 Oct;46(2):124-8
pubmed: 19631583